Senores has an interesting business model, focusing on generic product identification and development. For the commercialisation and marketing of those products, it has tied up with large generic players.
The consolidation is likely to continue until the benchmark indices decisively break the tight range of the past four days on either side. Below are some trading ideas for the near term.
The company’s India revenues grew 9 per cent to Rs 524 crore, while the US generics were up 6 per cent at Rs 390 crore in the quarter, the company said in the filing.